Hyrimoz

Active Ingredient(s): Adalimumab-adaz
FDA Approved: * October 30, 2018
Pharm Company: * SANDOZ INC
Category: Immunosuppressive

Adalimumab, sold under the brand name Humira, among others, is a monoclonal antibody used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis.[5][6][7] It is administered by injection under the skin.[5] Common side effects include upper respiratory tract infections, pain at the site o... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Hyrimoz 80 mg/.8ml Subcutaneous Injection, Solution
NDC: 61314-454
Labeler:
Sandoz Inc
Hyrimoz 40 mg/.4ml Subcutaneous Injection, Solution
NDC: 61314-473
Labeler:
Sandoz Inc
Hyrimoz 20 mg/.2ml Subcutaneous Injection, Solution
NDC: 61314-476
Labeler:
Sandoz Inc
Hyrimoz 10 mg/.1ml Subcutaneous Injection, Solution
NDC: 61314-509
Labeler:
Sandoz Inc
HyrimozHyrimoz Kit
NDC: 61314-517
Labeler:
Sandoz Inc
HyrimozHyrimoz Kit
NDC: 61314-531
Labeler:
Sandoz Inc
Hyrimoz 40 mg/.4ml Subcutaneous Injection, Solution
NDC: 83457-100
Labeler:
Cordavis Limited
Hyrimoz 40 mg/.4ml Subcutaneous Injection, Solution
NDC: 83457-101
Labeler:
Cordavis Limited
Hyrimoz 40 mg/.8ml Subcutaneous Injection, Solution
NDC: 83457-102
Labeler:
Cordavis Limited
Hyrimoz 40 mg/.8ml Subcutaneous Injection, Solution
NDC: 83457-103
Labeler:
Cordavis Limited

Related Brands

Drugs with the same active ingredients